Project Santa Fe Foundation (PSFF), the not-for-profit accelerating the Clinical Lab 2.0 movement (CL2.0) and defining the future valuation of the clinical laboratory, proudly announces the unanimous election of Nancy Stratton, Chief Executive Officer of COLA, as its newest board member. The appointment comes as a testament to Ms. Stratton’s exceptional leadership and expertise in the field of clinical laboratory services.
Says Khosrow Shotorbani, President & Executive Director of Project Santa Fe Foundation, “We are thrilled that Ms. Stratton has elected to join our Board of Directors. As CEO of COLA, she has consistently demonstrated a profound commitment to fostering innovation, best practices, and industry excellence. Her visionary leadership has significantly impacted the advancement of clinical laboratory services, making her an invaluable asset to the Clinical Lab 2.0 Movement as we navigate changes transitioning to value-based care focused on improving outcome, intervention, prevention and reducing the total cost of delivery.”
Clinical Lab 2.0 aims to re-engineer the role of lab in the care continuum, aligning with the future of value-based healthcare. Ms. Stratton’s valuable experience and pioneering vision will undoubtedly contribute to fostering an environment of innovation, excellence and collaboration within the Foundation.
“It is an immense honor to join the esteemed board of Project Santa Fe Foundation. I firmly believe in the power of collaboration and knowledge-sharing to drive transformative change in the healthcare industry,” said Nancy Stratton. “As a board member, I look forward to working alongside other influential leaders to further the mission of Clinical Lab 2.0 and advance global healthcare through innovative laboratory-driven approaches.”
About Project Santa Fe Foundation & Clinical Lab 2.0
Project Santa Fe Foundation LLC (PSFF), 501c3, is a coalition of laboratory leaders, coming together to create a disruptive value paradigm and explore alternative business models that expand the role of diagnostic services in the future healthcare ecosystem. PSFF leverages laboratory medicine and pathology domain knowledge to establish the thought leadership, standards and evidence for Clinical Lab 2.0. Through the facilitation of diverse partner collaborations, PSFF aims to guide policies, transfer the knowledge and accelerate the Clinical Lab 2.0 movement across the industry. www.cl2lab.org
COLA, Inc. is a physician-directed organization whose purpose is to promote health and safety through accreditation and educational programs. In 1993, COLA was granted deemed status by CMS to provide laboratory accreditation. As a leading laboratory accreditor in the United States, COLA operates its laboratory accreditation program in accordance with a quality management system certified to ISO 9001. This means we offer our customers a unique, standardized program and staff dedicated to satisfaction and laboratory quality. Our Surveyors and Technical Advisors are guided by a coaching approach and uncomplicated quality engineered processes. Laboratories of all types and sizes are evaluated and mentored to produce the highest quality laboratory services and meet CLIA regulations.
COLA’s Board of Directors consists of representatives from three founding member organizations: the American Medical Association (AMA), American Academy of Family Physicians (AAFP) and the American College of Physicians (ACP).